We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Posters.
- Abstract
This document provides summaries of several research studies related to different aspects of hematology. The first study evaluates the use of peripheral blood minimal residual disease (MRD) analysis to guide the duration of therapy in chronic lymphocytic leukemia (CLL) patients. The second study explores the impact of immunoglobulin replacement therapy on infections in patients with relapsed/refractory multiple myeloma (RRMM) treated with elranatamab. The third study discusses the use of local cytogenetic testing in newly diagnosed multiple myeloma patients in the UK. These studies provide valuable insights into improving treatment strategies and patient outcomes in CLL and multiple myeloma.
- Subjects
PURE red cell aplasia; MAST cell disease; BRUTON tyrosine kinase; ERYTHROBLASTOSIS fetalis; PATIENTS' attitudes; LOW-molecular-weight heparin; VASCULAR cell adhesion molecule-1
- Publication
British Journal of Haematology, 2024, Vol 204, p36
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1111/bjh.19398